Mediar Therapeutics
- Total Funding
- $237.0M
- Last Round
- $76.0M Series BJun 2026
- Rounds
- 3
About
Biopharmaceutical company developing fibrosis and inflammation treatments.
Summary
Mediar Therapeutics is a Biotech company based in United States. It has raised $237.0M in total across 3 rounds, most recently a $76.0M Series B round in Jun 2026. Investors include ICG Life Sciences, Amplitude Ventures and Intermediate Capital Group.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jun 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Similar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...